Dysregulation of the Aβ pathway, including increased production or impaired clearance of Aβ, contributes to neurodegenerative cascades that precede tau pathology, synaptic failure, and cognitive decline in AD [366]. This evidence concerns the gene MAPT and Alzheimer disease.